Upstream Bio, Inc. UPB Income Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $2.85M+20.4% | $2.37M— | ||
| $136.81M+117% | $62.97M— | ||
| $26.41M+53.8% | $17.17M— | ||
| $163.22M+104% | $80.13M— | ||
| -$160.36M-106% | -$77.76M— | ||
| -5,618.8%-2,338pp | -3,281.2%— | ||
| $16.92M+13.1% | $14.96M— | ||
| -$143.44M-128% | -$62.81M-206% | ||
| -5,026%-2,376pp | -2,650%— | ||
| -$2.66— | —— | ||
| -$160.17M-106% | -$77.68M— | ||
| -5,612.2%-2,335pp | -3,277.4%— | ||
| -$160.36M-106% | -$77.76M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Upstream Bio, Inc.'s revenue?
- Upstream Bio, Inc. (UPB) generated $3.3M in revenue over the trailing twelve months, up 44.7% year over year.
- Is Upstream Bio, Inc. profitable?
- Upstream Bio, Inc. is not currently profitable: it reported a net loss of $156.8M over the trailing twelve months, a -4719.0% net margin.
- What is Upstream Bio, Inc.'s earnings per share?
- Upstream Bio, Inc.'s diluted EPS over the trailing twelve months is $-2.90.
- Where does Upstream Bio, Inc.'s income statement data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
